Skip to main content
All lobbying clients

ASSOCIATION OF CLINICAL RESEARCH ORGANIZATIONS

Lobbying client · District of Columbia · filed 2025 to 2026

trade association

$365,000 Reported spend
16 Filings counted
3 Outside firms hired
0 Bills named

Spend is reported income plus in-house expenses across 16 filings. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 3 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well.

 Who filed for this client 3

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Reported by year 2 years
  • 2026 $165,000 7 filings
  • 2025 $200,000 9 filings
 Issues lobbied 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 3
  • HOUSE OF REPRESENTATIVES 11
  • SENATE 11
  • Food & Drug Administration (FDA) 4
 Recent filings 16 total
Q3 report
MCLEOD STRATEGIES
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $10,000 income · posted Nov 3, 2026
View → Q3 report
LEAVITT PARTNERS, LLC
3rd Quarter 2026 (July 1 - Sep 30) · $45,000 income · posted Oct 20, 2026
View → Q2 report
MCLEOD STRATEGIES
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $10,000 income · posted Jul 21, 2026
View → Q2 report
LEAVITT PARTNERS, LLC
2nd Quarter 2026 (Apr 1 - June 30) · $45,000 income · posted Jul 15, 2026
View → Q1 report
MCLEOD STRATEGIES
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $10,000 income · posted May 11, 2026
View → Q1 report
LEAVITT PARTNERS, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · $45,000 income · posted Apr 20, 2026
View → Registration
LEAVITT PARTNERS, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · posted Feb 20, 2026
View → Q4 report
MCLEOD STRATEGIES
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $10,000 income · posted Jan 21, 2026
View → Q4 termination
WASHINGTON HEALTH STRATEGIES GROUP
4th Quarter 2025 (Oct 1 - Dec 31) · House · Senate · $40,000 income · posted Jan 21, 2026
View → Q3 report
MCLEOD STRATEGIES
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $10,000 income · posted Nov 6, 2025
View → Q3 report
WASHINGTON HEALTH STRATEGIES GROUP
3rd Quarter 2025 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Nov 6, 2025
View → Q2 report
MCLEOD STRATEGIES
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $10,000 income · posted Aug 5, 2025
View → Q2 report
WASHINGTON HEALTH STRATEGIES GROUP
2nd Quarter 2025 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Aug 5, 2025
View → Q1 report
WASHINGTON HEALTH STRATEGIES GROUP
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted May 1, 2025
View → Q1 report
MCLEOD STRATEGIES
1st Quarter 2025 (Jan 1 - Mar 31) · House · Senate · $10,000 income · posted May 1, 2025
View → Registration
MCLEOD STRATEGIES
1st Quarter 2025 (Jan 1 - Mar 31) · posted Jan 13, 2025
View →
 Affiliated organisations 1
  • WASHINGTON HEALTH STRATEGIES GROUP United States of America named on 1 filing

Section 6 of the LD-2: organisations that contribute to or take part in this client's lobbying.

Keep going

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem